282 related articles for article (PubMed ID: 22504829)
1. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
Curtis JR; John A; Baser O
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1282-91. PubMed ID: 22504829
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.
An J; Alemao E; Reynolds K; Kawabata H; Solomon DH; Liao KP; Niu F; Cheetham TC
J Rheumatol; 2016 Nov; 43(11):1989-1996. PubMed ID: 27585690
[TBL] [Abstract][Full Text] [Related]
3. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study.
Myasoedova E; Gabriel SE; Green AB; Matteson EL; Crowson CS
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1592-9. PubMed ID: 23592565
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH; Stanwix AE; Joffe BI
Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
[TBL] [Abstract][Full Text] [Related]
5. Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Hollan I; Ronda N; Dessein P; Agewall S; Karpouzas G; Tamargo J; Niessner A; Savarese G; Rosano G; Kaski JC; Wassmann S; Meroni PL
Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):104-114. PubMed ID: 31397840
[TBL] [Abstract][Full Text] [Related]
6. Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.
Robertson J; Peters MJ; McInnes IB; Sattar N
Nat Rev Rheumatol; 2013 Sep; 9(9):513-23. PubMed ID: 23774906
[TBL] [Abstract][Full Text] [Related]
7. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
Liao KP; Liu J; Lu B; Solomon DH; Kim SC
Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
[TBL] [Abstract][Full Text] [Related]
8. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
Tournadre A; Pereira B; Dubost JJ; Rincheval N; Rat AC; Combe B; Soubrier M
Clin Exp Rheumatol; 2017; 35(2):296-302. PubMed ID: 28079508
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs.
Sánchez T; Contreras-Yáñez I; Elías-López D; Aguilar Salinas CA; Pascual-Ramos V
Clin Exp Rheumatol; 2014; 32(4):509-15. PubMed ID: 25005131
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.
Halacoglu J; Shea LA
J Cardiovasc Transl Res; 2020 Oct; 13(5):878-890. PubMed ID: 32080804
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
[TBL] [Abstract][Full Text] [Related]
12. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis.
Nurmohamed MT
Vasc Health Risk Manag; 2007; 3(6):845-52. PubMed ID: 18200805
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.
Mishra R; Singh A; Chandra V; Negi MP; Tripathy BC; Prakash J; Gupta V
Rheumatol Int; 2012 Aug; 32(8):2377-82. PubMed ID: 21644045
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritis.
Bili A; Morris SJ; Sartorius JA; Kirchner HL; Antohe JL; Dancea S; Wasko MC
J Rheumatol; 2012 May; 39(5):946-8. PubMed ID: 22467937
[TBL] [Abstract][Full Text] [Related]
17. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.
Chen DY; Chen YM; Hsieh TY; Hsieh CW; Lin CC; Lan JL
Arthritis Res Ther; 2015 Mar; 17(1):52. PubMed ID: 25889426
[TBL] [Abstract][Full Text] [Related]
18. Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis.
Naerr GW; Rein P; Saely CH; Drexel H
Vascul Pharmacol; 2016 Jun; 81():22-30. PubMed ID: 26903239
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment.
Akiyama M; Mawatari T; Nakashima Y; Miyahara H; Yamada H; Okazaki K; Fukushi J; Kondo M; Kishimoto J; Hashimura C; Iwamoto Y
Clin Rheumatol; 2015 Nov; 34(11):1867-75. PubMed ID: 26292631
[TBL] [Abstract][Full Text] [Related]
20. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]